Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium

Vascular Health and Risk Management

Volumn 7, Issue 1, 2011, Pages 719-724

  Roy, Sion K ^a   Cespedes, Albert ^a   Li, Dong ^a   Choi, Tae Young ^a   Budoff, Matthew J ^a  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Calcium; Coronary artery disease; Kidney disease

Indexed keywords

AGED; ARTICLE; BLOOD VESSEL CALCIFICATION; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR CALCIFICATION;

EID: 84862134364     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S24536     Document Type: Article

References (33)

1. Schiffrin EL, Lipman ML, Mann JFE. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116:85-97.
2. Budoff MJ, Gul KM. Expert review on coronary calcium. Vasc Health Risk Manag. 2008;4(2):315-324.
3. Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002;39(4):695-701.
4. McCullough PA, Agarwal M, Agrawal V. Review article: risks of coronary artery calcification in chronic kidney disease: do the same rules apply? Nephrology (Carlton). 2009;14:428-436.
5. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
6. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet. 2000;356:147-152.
7. Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol. 2006;290:F262-F272.
8. Blake JK, Ridker PM. C-reactive protein and other inflammatory risk factors in acute coronary syndromes. J Am Coll Cardiol. 2003;42(6): 1142-1143.
9. Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004;65:1009-1016.
10. Hage FD, Venkataraman R, Zoghbi GJ, Perry GJ, DeMattos AM, Iskandrian AE. The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol. 2009;53(23): 2129-2140.
11. Sechi LA, Zingaro L, De Carli S, Sechi G, Catena C, Falleti E. Increased serum lipoprotein (a) levels in patients with early renal failure. Ann Intern Med. 1998;129:457-461.
12. Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest. 1996;56:41-46.
13. Nangaku M, Eckardt KU. Pathogenesis of renal anemia. Semin Nephrol. 2006;26(4):261-268.
14. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-470.
15. Carr JJ, Nelson JC, Wong ND, et al. Calcified coronary artery plaque measurement with cardiac ct in population based studies: standardized protocol of multi-ethnic study of atherosclerosis (MESA) and coronary artery risk development in young adults (CARDIA) study. Radiology. 2005;234:35-43.
16. Agatston AS, Janowitz WR, Hildner FJ, Zusmer MR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832.
17. National Kidney Foundation (NKF) Kidney Disease Outcomes Quality Initiative. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification; part 4 [web page on the Internet]. New York, NY: NKF; 2002. Available from: http:// www.kidney.org/professionals/kdoqi/guidelines_ckd/p4_class_g1.htm. Accessed April 1, 2011.
18. Ardehali R, Nasir K, Kolandaivelu A, Budoff MJ, Blumenthal RS. Screening patients for subclinical atherosclerosis with non-contrast cardiac CT. Atherosclerosis. 2007;192(2):235-242.
19. Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis. 2004;44:1024-1030.
20. Kramer H, Toto R, Peshock R, Cooper R, Victor R. Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study. J Am Soc Nephrol. 2005;16:507-513.
21. Budoff MJ, Rader DJ, Reilly MP, et al. Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) study. Am J Kidney Dis. Epub July 23, 2011.
22. Haydar AA, Hujairi NMA, Covic AA, Pereira D, Rubens M, Goldsmith DJA. Coronary artery calcification is related to atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcification scores and coronary angiography. Nephrol Dial Transplant. 2004;19:2307-2312.
23. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007;49(18):1860-1870.
24. Mclelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the multi-ethnic study of atherosclerosis (MESA). Circulation. 2006;113(1):30-37.
25. Ix JH, Katz R, Kestenbaum B, et al. Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol. 2008;19:579-585.
26. Parikh NI, Hwang SJ, Larson MG, Hoffmann, et al. Indexes of Kidney Function and Coronary Artery and Abdominal Aortic Calcium (from the Framingham Offspring Study). Am J Cardiol. 2008;102:440-443.
27. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McLellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002;137:555-562.
28. NKF Kidney Disease Outcomes Quality Initiative. KDOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease [web page on the Internet]. New York, NY: NKF; 2003. Available from: http://www.kidney.org/professionals/kdoqi/guidelines_lipids/ index.htm. Accessed November 12, 2010.
29. Peralta CA, Hicks LS, Chertow GM, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2002;45;1119-1124.
30. Stadler SL, Bhardwaja B, Olson KL, Powers JD, Lanese D. An assessment of cholesterol goal attainment in patients with chronic kidney disease. J Clin Lipidol. 2010;4(4):298-304.
31. Shepherd J, Kastelein JJP, Bittner V, et al. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: The TNT (Treating to New Targets) Study. J Am Coll Cardiol. 2008;51:1448-1454.
32. Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377(9784):2181-2192.
33. NKF Kidney Disease Outcomes Quality Initiative. KDOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease [web page on the Internet]. New York, NY: NKF; 2004. Available from: http://www.kidney.org/professionals/kdoqi/ guidelines_bp/index.htm. Accessed November 12, 2010.